Literature DB >> 17506735

Microbial growth in propofol formulations with disodium edetate and the influence of venous access system dead space.

T Fukada1, M Ozaki.   

Abstract

Propofol formulated in lipid supports microbial growth. We hypothesised that propofol with disodium edetate would suppress microbial growth more than propofol without disodium edetate. We examined bacterial growth in vitro and bacterial survival in the dead space of different venous access systems. Bacteria in propofol with disodium edetate (Diprivan; AstraZeneca, London, UK) and without disodium edetate (1% Propofol inj. 'Maruishi'; Maruishi Pharmaceutical Co. Ltd, Osaka, Japan) survived and grew in the dead space of the venous access systems, although propofol with disodium edetate suppressed bacterial growth more than propofol without. Disodium edetate is effective in retarding microbial growth. However, for prevention of healthcare-associated infections, medical professionals should maintain strict aseptic precautions when handling propofol, use disodium edetate-containing formulations, and should consider using venous access systems without dead space.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17506735     DOI: 10.1111/j.1365-2044.2007.05002.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  5 in total

1.  Leaving more than your fingerprint on the intravenous line: a prospective study on propofol anesthesia and implications of stopcock contamination.

Authors:  Devon C Cole; Tezcan Ozrazgat Baslanti; Nikolaus L Gravenstein; Nikolaus Gravenstein
Journal:  Anesth Analg       Date:  2015-04       Impact factor: 5.108

2.  Novel lipid and preservative-free propofol formulation: properties and pharmacodynamics.

Authors:  François Ravenelle; Sandra Gori; Dorothée Le Garrec; David Lessard; Laibin Luo; Dana Palusova; J Robert Sneyd; Damon Smith
Journal:  Pharm Res       Date:  2007-11-21       Impact factor: 4.200

3.  Propofol increases morbidity and mortality in a rat model of sepsis.

Authors:  Martin Schläpfer; Tobias Piegeler; Randal O Dull; David E Schwartz; Mao Mao; Marcelo G Bonini; Birgit Roth Z'Graggen; Beatrice Beck-Schimmer; Richard D Minshall
Journal:  Crit Care       Date:  2015-02-19       Impact factor: 9.097

4.  The effect of implementing an aseptic practice bundle for anaesthetists to reduce postoperative infections, the Anaesthetists Be Cleaner (ABC) study: protocol for a stepped wedge, cluster randomised, multi-site trial.

Authors:  Alan F Merry; Derryn A Gargiulo; Ian Bissett; David Cumin; Kerry English; Christopher Frampton; Richard Hamblin; Jacqueline Hannam; Matthew Moore; Papaarangi Reid; Sally Roberts; Elsa Taylor; Simon J Mitchell
Journal:  Trials       Date:  2019-06-10       Impact factor: 2.279

5.  Infectious Disease Risk Associated with Contaminated Propofol Anesthesia, 1989-2014(1).

Authors:  Andrés Zorrilla-Vaca; Jimmy J Arevalo; Kevin Escandón-Vargas; Daniel Soltanifar; Marek A Mirski
Journal:  Emerg Infect Dis       Date:  2016-06       Impact factor: 6.883

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.